Joshua Vogel | Burnet Institute

Professor Joshua Vogel

Co-Program Director, Women’s, Children’s and Adolescents’ Health; Co-Head, Global Women’s and Newborn’s Health Group; Senior Principal Research Fellow

The World Health Organization ACTION-I (Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns) Trial: a multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries.

WHO ACTION Trials Collaborators

The World Health Organization ACTION-I (Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns) Trial: a multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries.

Pregnancy outcomes of women with previous caesarean sections: Secondary analysis of World Health Organization Multicountry Survey on Maternal and Newborn Health.

Kietpeerakool C, Lumbiganon P, Laopaiboon M, Rattanakanokchai S, Vogel JP, Gülmezoglu AM

Pregnancy outcomes of women with previous caesarean sections: Secondary analysis of World Health Organization Multicountry Survey on Maternal and Newborn Health.

Gender balance in WHO panels for guidelines published from 2008 to 2018.

Bohren MA, Javadi D, Vogel JP

Gender balance in WHO panels for guidelines published from 2008 to 2018.

An outcome-based definition of low birthweight for births in low- and middle-income countries: a secondary analysis of the WHO global survey on maternal and perinatal health.

Laopaiboon M, Lumbiganon P, Rattanakanokchai S, Chaiwong W, Souza JP, Vogel JP, Mori R, Gülmezoglu AM

An outcome-based definition of low birthweight for births in low- and middle-income countries: a secondary analysis of the WHO global survey on maternal and perinatal health.

A systematic review of the cost-effectiveness of uterotonic agents for the prevention of postpartum hemorrhage.

Lawrie TA, Rogozińska E, Sobiesuo P, Vogel JP, Ternent L, Oladapo OT

A systematic review of the cost-effectiveness of uterotonic agents for the prevention of postpartum hemorrhage.

The burden of severe maternal outcomes and indicators of quality of maternal care in Nigerian hospitals: a secondary analysis comparing two large facility-based surveys.

Vogel JP, Fawole B, Adeniran AS, Adegbola O, Oladapo OT

The burden of severe maternal outcomes and indicators of quality of maternal care in Nigerian hospitals: a secondary analysis comparing two large facility-based surveys.

11
12
13
14
15
16

Subscribe to Burnet